Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-5-17
pubmed:abstractText
The new combined estrogen & progestin contraceptive patch Ortho Evra was approved by the FDA in December 2001. To date, there is a paucity of data regarding its use in the adolescent age group. We examined adolescents' experience with this new contraceptive method.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1083-3188
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
85-90
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:15897103-Abdomen, pubmed-meshheading:15897103-Acne Vulgaris, pubmed-meshheading:15897103-Administration, Cutaneous, pubmed-meshheading:15897103-Adolescent, pubmed-meshheading:15897103-Attitude to Health, pubmed-meshheading:15897103-Breast, pubmed-meshheading:15897103-Buttocks, pubmed-meshheading:15897103-Condoms, pubmed-meshheading:15897103-Contraceptives, Oral, Combined, pubmed-meshheading:15897103-Drug Carriers, pubmed-meshheading:15897103-Dysmenorrhea, pubmed-meshheading:15897103-Ethisterone, pubmed-meshheading:15897103-Female, pubmed-meshheading:15897103-Headache, pubmed-meshheading:15897103-Humans, pubmed-meshheading:15897103-Menstrual Cycle, pubmed-meshheading:15897103-Menstruation, pubmed-meshheading:15897103-Nausea, pubmed-meshheading:15897103-Norgestrel, pubmed-meshheading:15897103-Oximes, pubmed-meshheading:15897103-Patient Dropouts, pubmed-meshheading:15897103-Patient Satisfaction
pubmed:year
2005
pubmed:articleTitle
Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
pubmed:affiliation
Division of Adolescent Medicine, Hasbro Children's Hospital, Brown University, Providence, Rhode Island 02903, USA. zharel@lifespan.org
pubmed:publicationType
Journal Article